PD-L1 is the primary negative immune regulatory molecule in tumour cells; it is also found in immune cells and has been widely targeted in immunotherapy for its ability to suppress T cells and its contribution to immune evasion [185]. The gene discussed is CD274; the disease is neoplasm.